✦ LIBER ✦

Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer

✍ Scribed by Rosenberg, S. A.; Lotze, M. T.; Yang, J. C.; Topalian, S. L.; Chang, A. E.; Schwartzentruber, D. J.; Aebersold, P.; Leitman, S.; Linehan, W. M.; Seipp, C. A.; White, D. E.; Steinberg, S. M.

Book ID: 121716951
Publisher: Oxford University Press
Year: 1993
Tongue: English
Weight: 962 KB
Volume: 85
Category: Article
ISSN: 0027-8874
DOI: 10.1093/jnci/85.8.622

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase iii randomized trial of interleuki

Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma

✍ Teresa Murray Law; Robert J. Motzer; Madhu Mazumdar; Kenneth W. Sell; Philip Wal 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

Background. Treatment with interleukin-2 (IL-2) and lymphokine-activated killer cells (LAK) resulted in responses in some patients with advanced renal cell carcinoma (RCC). However, the relative therapeutic benefit of the addition of LAK to IL-2 was unknown. Methods. A randomized Phase I11 trial wa

Evaluation of the treatment of 62 patien

Evaluation of the treatment of 62 patients with advanced cancer by using lymphokine-activated killer cells plus interleukin-2

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Continuous infusion of recombinant inter

Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma

✍ Palmer, Peter A.; Vinke, Jan; Evers, Pauline; Pourreau, Catherine; Oskam, Ralph; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 876 KB

Radiation therapy alone or combined with

Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: Report of an rtog prospective randomized trial

✍ Joseph R. Simpson; Madeline Bauer; Carlos A. Perez; Todd H. Wasserman; Bahman Em 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 1013 KB

An open-label, randomized trial of the e

An open-label, randomized trial of the effects of macrophage versus granulocyte colony-stimulating factor on natural killer cell activity, lymphokine activated killer cell activity, interleukin-2 production, and leukocyte count in patients after chemotherapy for ovarian cancer

✍ Mitsuaki Suzuki; Michitaka Ohwada; Yoshio Shimizu; Muneo Yamada; Ikuo Sato 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 381 KB

TREATMENT OF A PATIENT IN A RELAPSE AFTE

TREATMENT OF A PATIENT IN A RELAPSE AFTER BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH THE SYSTEMIC ADMINISTRATION OF ALLOGENEIC LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2

✍ Toshihisa Komori; Haruo Sugiyama; Hiroyasu Ogawa; Yoshihiro Oka; Seigou Miyake; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB